Gala vs Hims: Which GLP-1 Provider Is Better?
Short answer: Gala scores higher on our rubric, 7.2/10 against 5.9/10. Full reasoning, pricing and the cases where the other one wins are below.
Gala beats Hims overall, scoring 7.2/10 vs 5.9/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; Hims is $188 first month, then $298/mo. Choose Gala for patients who want gala's low yearly-plan rate on compounded glp-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors.
A side-by-side look at Gala and Hims to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Gala
#30 of 54Telehealth platform whose compounded GLP-1 line covers semaglutide and tirzepatide, sold as a $149/mo microdose tier and a $179/mo all-doses tier, alongside brand-name Ozempic at $1,299/mo and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. of Wilmington, Delaware, with care delivered by OpenLoop-affiliated medical groups; Gala states it provides administrative, technology and management services and does not itself provide medical care. It is LegitScript verified and promotes a free Gala GLP-1 app for in-treatment dosing, weight and side-effect logging.
Visit GalaHims
#40 of 54The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, Zepbound and Mounjaro paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 2.9 stars across 9,185 reviews (checked 2026-09-03), below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 29%, the highest 1-star rate in our table, clustered around subscription and billing complaints.
Visit Hims| Feature | Gala | Hims |
|---|---|---|
| Why each one | A free Gala GLP-1 companion app, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; confirm the app's availability for your phone before enrolling. | The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 2.9 Trustpilot rating that lags peers. |
| Our Score | 7.2/10 | 5.9/10 |
| Headline Price | from $149/mo | $188 first month, then $298/mo |
| Medication Type | Both | Brand |
| Insurance Accepted | No | No |
| Best For | Patients who want Gala's low yearly-plan rate on compounded GLP-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors |
| Watch out for | Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line. | Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. |
| Ranking | #30 | #40 |
| Get started | Visit Gala | Visit Hims |
Pros & Cons Compared
Gala
Pros
- +Compounded GLP-1 is $149/mo on the microdose tier or $179/mo with all doses included on the yearly plan, and Gala's about page lists GLP-1 medication from $199/mo on a 3-month plan
- +A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
- −Product pages quote only the yearly subscription, its about page lists a 3-month GLP-1 plan from $199/mo, and the plan you actually get is set at checkout after you log in
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and Gala publishes no lab panel for the GLP-1 program, no named medical director and no specialty obesity oversight; its refund policy does list lab services among what the subscription price may cover
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +9,185 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 2.9 stars across 9,185 reviews (checked 2026-09-03), below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −29% of Trustpilot reviews are 1-star (checked 2026-09-03), the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −Hims says GLP-1s are not yet available in all 50 states and does not publish which states are excluded, so confirm your own state before you pay the first membership fee.
- −Hims states in its own terms that it is not a HIPAA covered entity, and that anything you send it outside diagnosis, treatment or prescription fulfilment is governed only by its privacy policy. The pending FTC complaint concerns health information shared with advertising platforms, so read that disclosure before you fill in the intake.
- −The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
Our Verdict
Gala edges out Hims with a score of 7.2/10 vs 5.9/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; Hims is $188 first month, then $298/mo. Gala offers both brand-name and compounded medications, giving you more flexibility.
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both Gala and Hims start above the cheapest complete recurring program we track. Across all 54 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Gala and Hims.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Gala and FeelGoodfrom $149/mo
- Compare Gala and GoodRx Care$119/mo subscription + medication
- Compare Gala and Tonik Wellnessfrom $149/mo
- Compare Hims and SnagRxpublished $99/mo; total not verified
- Compare Hims and Luvo Healthfrom $249/mo
- Compare Hims and HealthRXfrom $99/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Gala legit and is Hims legit, with the verification evidence behind each answer.
Our pick of these two: Gala · 7.2/10